Pei-Yin Lim

Pei-Yin Lim has extensive work experience in the field of research and development, particularly in the areas of virology and immunology. They are currently working as a Lead Scientist in Preclinical R&D at Hilleman Laboratories since July 2022. Prior to this role, they held the position of Senior Scientist in Preclinical R&D at the same company from November 2021 to July 2022.

Before joining Hilleman Laboratories, Pei-Yin Lim worked as a Senior Research Fellow at A*STAR - Agency for Science, Technology and Research from August 2018 to August 2021.

From 2012 to 2017, Pei-Yin Lim worked at Sentinext Therapeutics Sdn Bhd, where they held various roles including Laboratory Director, Senior Scientist, and Research Scientist. During their time at Sentinext Therapeutics, they played a crucial role in the successful transition of the Enterovirus A71 virus-like particle vaccine through Phase I approval. They were also instrumental in achieving significant recognition for Sentinext Therapeutics, including the BioInnovation of the Year Award and BioPharma Asia Award in 2015. In addition, Pei-Yin Lim participated in a collaborative study organized by the World Health Organization to establish the first international standard for anti-Enterovirus A71 serum.

Pei-Yin Lim's earlier work experience includes serving as a Postdoctoral Research Associate and Teaching Instructor at the University of Wisconsin-Madison from 2009 to 2011. They also worked as a Howard Hughes Medical Institute Teaching Fellow at the Wisconsin Program for Scientific Teaching, University of Wisconsin-Madison from 2010 to 2011.

Prior to their time at the University of Wisconsin-Madison, Pei-Yin Lim worked as a Postdoctoral Research Associate at Wadsworth Center from 2007 to 2009. They also served as a Teaching Assistant at the University of Wisconsin-Madison from 2003 to 2004.

Pei-Yin Lim's earliest work experience was as a Lab Technician at the University of Missouri in 2000.

Throughout their career, Pei-Yin Lim has showcased their expertise in virology, immunology, and research and development, contributing to the development and characterization of vaccines and leading analytical and scientific teams.

Pei-Yin Lim earned a Bachelor of Science (BSc) in Biochemistry with a minor in Chemistry from the University of Missouri-Columbia, where they studied from 1998 to 2000. Pei-Yin then pursued further education and completed their Doctor of Philosophy (PhD) in Biochemistry and Virology at the University of Wisconsin-Madison, studying from 2001 to 2007. Pei-Yin Lim also obtained a certification in "Vaccine Trials: Methods and Best Practices" from Coursera, though the specific month and year of obtaining the certification are not provided.